524444
Evexia Lifecare financials
- Market cap
- ₹297 Cr
- Sector
- Chemicals
What Evexia Lifecare does
Evexia Lifecare Limited manufactures and trades in pharmaceuticals, chemicals and lifecare products. Beyond this core business, the company holds majority equity stakes in a cluster of group companies spanning edible-oil processing (Kavit Edible Oil Limited, 80%), diagnostic centres (Vittal's MediCare Private Limited, 51%), chemical/biological testing and research services (Revin Labs Private Limited, 50%), pharmaceuticals and chemicals trading (Diponed Bio Private Limited, 65%), and business-process outsourcing (Kavit Trading Private Limited, 70%).
Segments
- Pharmaceuticals, chemicals & lifecare products
- Edible oil
- Diagnostics
- Chemical/biological testing & research
- Pharma & chemicals trading
- Business process outsourcing (BPO/KPO)
- Majority-owned group companies
- 5 (edible oil, diagnostics, testing labs, pharma trading, BPO/KPO)
- Stake in Kavit Edible Oil Limited (edible oil)
- 80%
- Stake in Kavit Trading Private Limited (BPO/KPO)
- 70%
- Stake in Diponed Bio Private Limited (pharma/chemicals trading)
- 65%
- Stake in Vittal's MediCare Private Limited (diagnostic centres)
- 51%
- Stake in Revin Labs Private Limited (testing & research)
- 50%
Quarterly results
Q1 FY27: revenue up 39.8%, net profit down 33.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 27 | 22 | 24 | 22 | 26 −4% | 25 +16% | 37 +56% | 31 +40% |
| EBITDA | 1 | 0 | 1 | 1 | 0 −91% | 0 +47% | 1 −17% | 1 −50% |
| Net profit | 1 | 0 | 0 | 1 | 0 −61% | 0 +142% | 1 +152% | 0 −33% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −28.3% 1Y
1Y: ₹2.3 on 10 Sept 2025 → ₹1.65. High ₹2.3 (10 Sept 2025), low ₹0.49 (2 Apr 2026).
Financials, as filed
Revenue grew 16.5% a year over 3 years, FY23 to FY26. Operating margin widened to 2.3%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹70 Cr | ₹56 Cr | ₹93 Cr | ₹110 Cr |
| Operating profit | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr |
| Operating margin | 0.8% | 3.3% | 3.1% | 2.3% |
| Interest | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| Net profit | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
| Net margin | 0.8% | 2.2% | 1.7% | 1.9% |
| Cash from operations | ₹-3 Cr | ₹17 Cr | ₹-2 Cr | ₹-23 Cr |
| Free cash flow | ₹-6 Cr | ₹17 Cr | ₹-2 Cr | ₹-27 Cr |
| ROCE | 0.0% | 0.0% | 0.0% | — |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Equity capital | ₹62 Cr | ₹62 Cr | ₹62 Cr | ₹66 Cr | ₹71 Cr | ₹188 Cr |
| Reserves | ₹16 Cr | ₹18 Cr | ₹19 Cr | ₹24 Cr | ₹59 Cr | ₹379 Cr |
| Borrowings | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹705 Cr | ₹686 Cr | ₹1.2k Cr |
| Other liabilities | ₹139 Cr | ₹56 Cr | ₹41 Cr | ₹52 Cr | ₹67 Cr | ₹65 Cr |
| Total liabilities | ₹224 Cr | ₹142 Cr | ₹127 Cr | ₹848 Cr | ₹883 Cr | ₹1.9k Cr |
| Fixed assets | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹11 Cr | ₹11 Cr | ₹14 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Investments | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹704 Cr | ₹724 Cr | ₹879 Cr |
| Other assets | ₹215 Cr | ₹132 Cr | ₹115 Cr | ₹132 Cr | ₹148 Cr | ₹959 Cr |
| Total assets | ₹224 Cr | ₹142 Cr | ₹127 Cr | ₹848 Cr | ₹883 Cr | ₹1.9k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, the public added +0.14 pp while promoters trimmed −0.13 pp. The shareholder count shrank 4% to 1,44,756.
- Promoters
- 3.4%
- DIIs
- 0.1%
- Public
- 96.5%
Since Jun 2025
- Public +0.14 pp
- Promoters −0.13 pp
- FIIs 0.00 pp
How it drifted, 12 quarters
Over this window the public went from 86.5% to 96.5% — +10.1 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 9.9%, FIIs 3.4%, DIIs 0.3%, Public 86.5%.Dec '23: Promoters 9.9%, FIIs 1.4%, DIIs 0.3%, Public 88.4%.Mar '24: Promoters 9.3%, DIIs 0.3%, Public 90.5%.Jun '24: Promoters 6.3%, FIIs 1.0%, DIIs 0.2%, Public 92.5%.Sep '24: Promoters 5.9%, FIIs 1.5%, DIIs 0.2%, Public 92.5%.Dec '24: Promoters 3.5%, FIIs 0.2%, DIIs 0.1%, Public 96.3%.Mar '25: Promoters 3.5%, FIIs 0.2%, DIIs 0.1%, Public 96.3%.Jun '25: Promoters 3.5%, DIIs 0.1%, Public 96.4%.Sep '25: Promoters 3.4%, FIIs 0.5%, DIIs 0.1%, Public 96.1%.Dec '25: Promoters 3.5%, FIIs 0.5%, DIIs 0.1%, Public 95.9%.Mar '26: Promoters 3.4%, FIIs 0.1%, DIIs 0.1%, Public 96.4%.Jun '26: Promoters 3.4%, DIIs 0.1%, Public 96.5%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Moolchand Kiran Kumar Jain newly disclosed 5.86% held
- R G Family +0.16 pp 2.31% held
- Abhay Bharatbhai Shah +0.09 pp 1.16% held
The same filing shows 2 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Evexia Lifecare above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Wave Capital Ltd FPI fund | 12.17% | unchanged |
| Nova Global Opportunities Fund Pcc - Touchstone FPI fund | 8.07% | unchanged |
| Moolchand Kiran Kumar Jain | 5.86% | newly disclosed |
| Aio Growth Capital Fund Spc VC / PE | 4.72% | −3.78 pp |
| M7 Global Fund Pcc - Cell Dewcap Fund FPI fund | 3.94% | unchanged |
| Zeal Global Opportunities Fund FPI fund | 2.34% | −5.53 pp |
| R G Family | 2.31% | +0.16 pp |
| Global Focus Fund FPI fund | 2.29% | unchanged |
| Nishchaya Tradings Private Limited | 1.98% | unchanged |
| Raghuvir International | 1.55% | unchanged |
| Jayeshbhai Raichand Bhai Thakkar | 1.30% | unchanged |
| Ravi Goyal | 1.23% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Evexia Lifecare
Guides on how to read this kind of business and the numbers that matter.